20-50731812-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032521.3(PARD6B):c.26C>T(p.Ala9Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000813 in 1,462,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032521.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARD6B | NM_032521.3 | c.26C>T | p.Ala9Val | missense_variant | 1/3 | ENST00000371610.7 | NP_115910.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARD6B | ENST00000371610.7 | c.26C>T | p.Ala9Val | missense_variant | 1/3 | 1 | NM_032521.3 | ENSP00000360672.2 | ||
PARD6B | ENST00000396039.1 | c.26C>T | p.Ala9Val | missense_variant | 1/3 | 1 | ENSP00000379354.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152112Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000800 AC: 6AN: 75026Hom.: 0 AF XY: 0.0000692 AC XY: 3AN XY: 43332
GnomAD4 exome AF: 0.0000839 AC: 110AN: 1310684Hom.: 0 Cov.: 31 AF XY: 0.0000882 AC XY: 57AN XY: 646006
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2024 | The c.26C>T (p.A9V) alteration is located in exon 1 (coding exon 1) of the PARD6B gene. This alteration results from a C to T substitution at nucleotide position 26, causing the alanine (A) at amino acid position 9 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at